Sökresultat - Annick Verhee

  • Visas 1 - 11 av 11 resultat
Förfina resultatet
  1. 1
    Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor

    Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor av Sven Eyckerman, D. Broekaert, Annick Verhee, Joël Vandekerckhove, Jan Tavernier

    Publicerad 2000
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit.

    Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. av Jan Tavernier, T Tuypens, Geert Plaetinck, Annick Verhee, Walter Fiers, René Devos

    Publicerad 1992
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.

    Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. av Jan Tavernier, T Tuypens, Annick Verhee, Geert Plaetinck, René Devos, José Van der Heyden, Yves Guisez, Christian Oefner

    Publicerad 1995
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist

    Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist av Frank Peelman, Katrien Van Beneden, Lennart Zabeau, Hannes Iserentant, Peter Ulrichts, Delphine Defeau, Annick Verhee, Dominiek Catteeuw, Dirk Elewaut, Jan Tavernier

    Publicerad 2004
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5.

    Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5. av René Devos, Yves Guisez, Sigrid Cornelis, Annick Verhee, José Van der Heyden, Michael Manneberg, H W Lahm, Walter Fiers, Jan Tavernier, Geert Plaetinck

    Publicerad 1993
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Selective Modulation of the Human Glucocorticoid Receptor Compromises GR Chromatin Occupancy and Recruitment of p300/CBP and the Mediator Complex

    Selective Modulation of the Human Glucocorticoid Receptor Compromises GR Chromatin Occupancy and Recruitment of p300/CBP and the Mediator Complex av Laura Van Moortel, Annick Verhee, Jonathan Thommis, René Houtman, Diana Melchers, Louis Delhaye, Chloé Van Leene, Madeleine Hellemans, Kris Gevaert, Sven Eyckerman, Karolien De Bosscher

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling

    A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling av Frank Peelman, N Vinaimont, Berlinda Vanloo, Christine Labeur, M. Rosseneu, Annick Verhee, J‐L. Verschelde, J. Vanderckove, Jan Tavernier, Sandrine Séguret-Macé, Nicolas Duverger, Gillian Hutchinson

    Publicerad 1998
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Trapping mammalian protein complexes in viral particles

    Trapping mammalian protein complexes in viral particles av Sven Eyckerman, Kevin Titeca, Emmy Van Quickelberghe, Eva Cloots, Annick Verhee, Noortje Samyn, Leentje De Ceuninck, Evy Timmerman, Delphine De Sutter, Sam Lievens, Serge Van Calenbergh, Kris Gevaert, Jan Tavernier

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

    A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment av Anje Cauwels, Sandra Van Lint, Geneviève Garcin, Jennyfer Bultinck, Franciane Paul, Sarah Gerlo, José Van der Heyden, Yann Bordat, Dominiek Catteeuw, Lode De Cauwer, Elke Rogge, Annick Verhee, Gilles Uzé, Jan Tavernier

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies

    Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies av Leander Huyghe, Alexander Van Parys, Anje Cauwels, Sandra Van Lint, Stijn De Munter, Jennyfer Bultinck, Lennart Zabeau, Jeroen Hostens, An Goethals, Nele Vanderroost, Annick Verhee, Gilles Uzé, Niko Kley, Frank Peelman, Bart Vandekerckhove, Peter Brouckaert, Jan Tavernier

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments

    Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments av Anje Cauwels, Sandra Van Lint, Franciane Paul, Geneviève Garcin, Stefaan De Koker, Alexander Van Parys, Thomas Wueest, Sarah Gerlo, José Van der Heyden, Yann Bordat, Dominiek Catteeuw, Elke Rogge, Annick Verhee, Bart Vandekerckhove, Niko Kley, Gilles Uzé, Jan Tavernier

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: